Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment on track in ASSIST-2 study of Telcyta

Dec. 22, 2004

Preclinical antitumor activity of the novel Hsp90 inhibitor IPI-504

Dec. 22, 2004

Avastin approved in Switzerland

Dec. 21, 2004

667-Coumate enters phase I development for breast cancer

Dec. 21, 2004

Perifosine shows promise in the treatment of metastatic breast cancer

Dec. 21, 2004

SB-715992 enters new phase II study for advanced ovarian cancer

Dec. 21, 2004

CXCR inhibition as a therapeutic strategy in leukemia

Dec. 21, 2004

Allos Therapeutics acquires license to chemotherapeutic agent RH1

Dec. 21, 2004

Exelixis plans phase I study of XL-880 for 2005

Dec. 21, 2004

No overall survival benefit with Iressa in ISEL study

Dec. 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...